Home
Notes
Drug Dealin Podcast
Sponsorships
About BPS
Consulting
Home
Notes
Drug Dealin Podcast
Sponsorships
About BPS
Consulting
Subscribe
Sign in
Latest
Top
Discussions
Last Week Tonight in BioPharma: Week of June 1st, 2026
RevMed PDAC data, IgAN opportunity, CAR-T for kidney transplant, NewLimit Series C, and much more
Jun 6
•
Big Pharma Sharma
6
2
May 2026
Last Week Tonight in BioPharma: Week of May 25th, 2026
Lilly' PCSK9 gene editing data, HBV functional cure, GLP-1 formulary update, Pfizer looks to China to reinvigorate its pipeline, and more!
May 31
•
Big Pharma Sharma
7
5
ChatGPT, Claude, or Gemini? Big Pharma Is Choosing Sides
I tracked 27 frontier-AI partnerships across 21 pharma companies. Here’s what the map looks like and what it means.
May 27
•
Big Pharma Sharma
3
2
Last Week Tonight in BioPharma: Week of May 18, 2026
Retatrutide wows, Sac-TMT continues to shine, Regeneron co-signs Parabilis, and much more!
May 24
•
Big Pharma Sharma
2
2
Last Week Tonight in BioPharma: Week of May 11th, 2026
Novo's early responders play, cleaning house at the FDA, IsoMorphic's $2.1B round, and more!
May 17
•
Big Pharma Sharma
3
2
1
We Know JAK About Myelofibrosis
Myelofibrosis treatment hasn't changed much for a long time. Is there a breakthrough on the horizon?
May 15
•
Big Pharma Sharma
3
2
Last Week Tonight in BioPharma: Week of May 4th
Happy Mother's Day! This week: Cytokinetics, Makary (almost) out, Roche buys PathAI, and more!
May 10
•
Big Pharma Sharma
2
Last Week Tonight in Biopharma: Week of April 27th, 2026
Sun Pharma buying Organon, AstraZeneca's dance with the ODAC, Intellia pays the "gene therapy tax", and IPOs are back!
May 3
•
Big Pharma Sharma
3
1
April 2026
Should You Be Allowed to Bet on Whether a Cancer Drug Works?
My initial view on prediction markets for clinical trials
Apr 30
•
Big Pharma Sharma
4
3
Last Week Tonight in BioPharma | Week of April 21st, 2026
Loss leader strategy, overreacting to early sales numbers, Trump is an ibogaine guy, and tariff math hits Japanese Pharma
Apr 26
•
Big Pharma Sharma
3
1
Last Week Tonight in BioPharma: April 11th - April 19th
Game-changer in pancreatic cancer, RFK peptide shenanigans are back, a huge GLP-1 IPO, Lilly buying another in vivo CAR-T (?) and much more
Apr 19
•
Big Pharma Sharma
5
3
The GLP-1 You Probably Haven't Heard Of
A look into what Lilly is trying to accomplish with once-monthly brenipatide
Apr 16
•
Big Pharma Sharma
5
4
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
